Healthcare & Life Sciences
Prelude Therapeutics
United Stateswww.preludetx.com
Prelude Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Prelude Therapeutics
Prelude Therapeutics is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Prelude Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule targeted therapies for oncology, including selective KAT6A degraders and mutant selective JAK2V617F inhibitors to address various cancers.
Explore Prelude Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.